Abiomed, inc. maintains earnings guidance for fiscal year 2020

Abiomed, inc. maintained earnings guidance for fiscal year 2020. the company is maintaining its fiscal year 2020 guidance for total revenues to be in the range of $885 million to $925 million, an increase of 15% to 20% over the prior year.
ABMD Ratings Summary
ABMD Quant Ranking